Wockhardt secures US FDA approval for ZAYNICH
Antibiotic approved for treatment of adults with complicated urinary tract infections caused by susceptible Gram-negative…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Lupin receives US FDA approval for generic colonoscopy preparation tablets
Approval grants Lupin 180-day generic drug exclusivity for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets in…
Sanofi launches AccelRare reduce India’s rare disease diagnosis challenge
Sanofi announced the India launch of AccelRare, an AI-powered digital pre-diagnosis tool designed to transform the way healthcare…
Review meeting held on WHO-ICHI Framework, National Health Intervention Codes for ASU
The Ministry of Ayush, Government of India, organised a high-level review meeting and consultative discussions on the development…
Lupin’s Ankleshwar facility receives EIR from US FDA
Global pharma major Lupin announced that it has received the Establishment Inspection Report (EIR) from the United States Food and…
MedTherapy details India manufacturing plans for CAR-T and gene therapies
MedTherapy, a cancer gene therapy biotechnology company with its global manufacturing facility based in NOIDA within New Delhi…
Science and affordability are at the centre of our cosmetics strategy
How is Leeford Healthcare approaching opportunities in the cosmetics space, and which areas are currently seeing the most…
Tecan establishes direct sales and specialist lab automation service operations in India
Tecan, a global provider of laboratory automation and solutions has announced the launch of direct operations in India, including…
An emerging disruption in drug traceability for India and beyond
Over the past two decades, I have worked closely on serialisation and traceability deployments in multiple markets, transitioning…
Regeneron to launch Global Capability Centre to scale operational excellence in Hyderabad
Regeneron Pharmaceuticals announced plans to establish the Regeneron Global Capability Centre (GCC) in Hyderabad, India — a…
China+1 moment for pharma: How India can convert opportunity into long-term contracts
The global healthcare industry has long relied on China for the majority of its active ingredients, APIs, and chemicals, making…
Navigating legal and regulatory landscape of GLP-1 drugs in India
India is currently facing a growing public health issue, with recent data showing that nearly a quarter of the adult population is…
Lupin receives China approval for Oseltamivir Phosphate oral suspension
Global pharma major Lupin announced that China’s National Medical Products Administration has approved its Abbreviated New Drug…
CDSCO clarifies injectables cannot be marketed as cosmetics, warns against misleading claims
Central Drugs Standard Control Organisation (CDSCO) has issued a public notice clarifying that cosmetic products cannot be…
Platinum Industries collaborates with Dr Abhigyan Upadhyay to lead new enterprise, Rivadu…
Platinum Industries, an innovation-driven specialty chemicals company announced its strategic entry into the life sciences sector,…
Venus Remedies receives Saudi FDA approval for Plerixafor
Venus Remedies, among the world's ten largest fixed-dosage injectable manufacturers, has received Marketing Authorization from the…
India’s first CAR T-Cell therapy shows durable results
In a major milestone in Indian oncology care, Immuneel Therapeutics’ Made-In-India CAR T-cell therapy has delivered the country’s…
Shaily announces approval, launch of customer combo product with ShailyPen Neo Device Technology
USFDA Tentative Approval, Health Canada Notice of Compliance, and India CDSCO approval have been secured for a customer's generic…
Dr. Reddy’s Laboratories launches oral semaglutide biosimilar ‘Obeda’ tablets in India
Dr. Reddy’s Laboratories, a global pharmaceutical company, announced the launch of its oral semaglutide biosimilar, indicated for…
MSME Pharma firms warn of rising compliance burden as regulatory costs surge: FOPE Study
India’s MSME pharmaceutical manufacturers are facing mounting financial and operational pressure due to recent regulatory reforms,…